Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Southwest Oncology Group Stories

2012-08-02 22:21:21

New treatment option extends median survival time by more than 6 months Postmenopausal women with the most common type of metastatic breast cancer now have a new treatment option that lengthens their lives, according a study led by UC Irvine oncologist Dr. Rita Mehta and conducted by the Southwest Oncology Group. The findings appear in the Aug. 2 issue of the New England Journal of Medicine. A combination of the two anti-estrogen drugs anastrozole and fulvestrant extended the median...

2012-04-19 02:29:22

SAN FRANCISCO, April 19, 2012 /PRNewswire/ -- MolecularHealth, a leader in clinico-molecular informatics((TM)), today announced that Stephan Brock, Ph.D., the company's president, showcased the use of clinico-molecular informatics for oncology treatment decision support at the SWOG Spring 2012 Group Meeting in San Francisco. SWOG (formerly Southwest Oncology Group) is one of the five cooperative groups that together comprise the National Cancer Institute's (NCI's) National...

2011-04-26 07:00:00

REDWOOD CITY, Calif., April 26, 2011 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the launch of RxPONDER S1007 (Rx for Positive Node, Endocrine Responsive Breast Cancer), a clinical trial being led by SWOG, one of the largest National Cancer Institute (NCI) supported cancer cooperative groups. The trial is designed to determine the effect of chemotherapy in breast cancer patients with one to three positive nodes who have a Recurrence Score® (RS)...

2010-04-09 10:22:00

Southwest Oncology Group, one of the nation's largest cancer clinical trial groups, funded through 2015. Core $63+ million grant largest ever to University of Michigan Medical School, where the Group is headquartered. ANN ARBOR, Mich., April 9 /PRNewswire-USNewswire/ -- Noting that the organization's research "has touched the lives of virtually every adult cancer patient in this nation," the National Cancer Institute (NCI) has renewed the Southwest Oncology Group's operating grants for...

2009-12-11 14:06:48

But second study finds a subset of patients who may not benefit Chemotherapy added to tamoxifen can improve outcomes for postmenopausal breast cancer patients, according to a landmark study by the Southwest Oncology Group. But a related study presented today at the 2009 San Antonio Breast Cancer Symposium finds that a multigene test on tumors can identify a subset of patients who may not benefit from that chemotherapy. Both studies were led by Dr. Kathy Albain, of Loyola University Health...

2009-11-24 15:51:00

DALLAS, Nov. 24 /PRNewswire-USNewswire/ -- The Baylor Charles A. Sammons Cancer Center has become a full member of one of the largest cancer clinical trials cooperative groups in the United States. Funded by research grants from the National Cancer Institute, Southwest Oncology Group conducts clinical trials to prevent and treat cancer in adults, and to improve the quality of life for cancer survivors. "Joining this prestigious group will allow us to offer additional, important clinical...

2009-07-13 07:19:51

An analysis of almost 20,000 patient records from the Southwest Oncology Group's database of clinical trials finds that African-American breast, ovarian, and prostate cancer patients tend to die earlier than patients of other races, even when they get identical medical treatment and other socioeconomic factors are controlled. The finding points to biological or genetic factors as the potential source of the survival gap. The study also found that when treatment was uniform and differences in...

2009-07-07 15:00:00

ANN ARBOR, Mich., July 7 /PRNewswire-USNewswire/ -- An analysis of almost 20,000 patient records from the Southwest Oncology Group's database of clinical trials finds, for the first time, that African-American breast, ovarian, and prostate cancer patients tend to die earlier than patients of other races even when they get identical medical treatment and other confounding socioeconomic factors are controlled for. The finding points to biological or host genetic factors as the potential source...